Treating cancer using “living drugs”
Harnessing the body’s immune system to kill tumor cells. The treatment method, known as Chimeric Antigen Receptor T-Cell therapy involves reengineering the immune cells (T-cells) obtained from the patient’s blood and giving it back after genetic modification. The modified immune cells (CAR T-cells), are capable of recognizing tumor cells and kill them.
